COMMUNICATIONS Monoclonal Antibody Aggregation Intermediates Visualized by Atomic Force Microscopy

Ubiquitous but highly variable processes of therapeutic protein aggregation re- main poorly characterized, especially in the context of common infusion reactions and clinical immunogenicity. Among the numerous challenges is the characterization of intermediate steps that lead to the appearance of precipitates. Although the biophysical methods for elucidation of secondary and tertiary structures as well as overall size distribution are typically well estab- lished in the development laboratories, the use of molecular scale imaging techniques is still relatively rare due to low throughput and technical complexity. In this work, we present the use of atomic force microscopy to examine morphology of monoclonal antibody aggregates. Despite varying in primary structure as a result of different complementarity defining regions, most an- tibodies studied exhibited a similar aggregation intermediate consisting of several monomers. However, the manner of subsequent condensation of these oligomers appeared to differ between the antibodies, suggesting stability-dependent mechanisms. © 2010 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 100:416-423, 2011